Is Coty (COTY) Undervalued After Q3 Earnings And The Marc Jacobs Beauty Relaunch?
Coty Inc. Class A COTY | 0.00 |
Coty (COTY) has been in focus after its fiscal Q3 2026 earnings, as the stock fell more than 20% and then partially recovered following the Marc Jacobs Beauty relaunch and the reinstatement of annual profit targets.
Beyond the immediate reaction to Q3 results, Coty’s recent moves, including the Marc Jacobs Beauty relaunch and the Coty Curated framework, come against a backdrop of a 1-year total shareholder return that declined 58% and a year to date share price return that declined 37%, suggesting sentiment has weakened over a longer period despite short term price swings.
If Coty’s recent volatility has you rethinking concentration in a single stock, it may be worth broadening your watchlist with companies exposed to long term themes such as 20 top founder-led companies
With Coty now trading at $1.95 after steep share price declines, at a sizable discount to analyst targets and some implied intrinsic value estimates, the key question is whether this represents genuine mispricing or whether markets are already accounting for its future growth potential.
Most Popular Narrative: 80.1% Undervalued
Coty is priced at $1.95 while the most followed narrative suggests a fair value of $9.78, a wide gap that reflects very different expectations about its long term potential.
Coty (NYSE: COTY) has spent years rebuilding itself after a period of brand sprawl and operational complexity. Once known primarily for mass-market fragrances and celebrity-driven beauty, the company is now reshaping its identity around focus, formulation quality, and consumer trust. That shift matters more today than ever, as beauty consumers become increasingly selective, not just about aesthetics, but about ingredients, safety, and long-term skin health.
Want to understand why this narrative supports a much higher fair value for Coty? It leans heavily on a reset profit profile, tightly managed margins, and a future earnings multiple that assumes real traction from its science focused repositioning. The full breakdown shows how those moving parts fit together to reach $9.78, and how sensitive that view is to the next few years of execution.
Result: Fair Value of $9.78 (UNDERVALUED)
However, this Coty narrative could be knocked off course if consumer brands fail to gain traction or if profitability remains under pressure despite current revenue and earnings trends.
Next Steps
If the mix of weak past returns and an undervalued Coty narrative feels conflicting, do not sit on the fence. Review the underlying metrics and check the 3 key rewards
Looking for more investment ideas beyond Coty?
If Coty has sharpened your focus on pricing, quality, and risk, use that momentum to scan a wider field of stocks that fit your own playbook.
Use the Simply Wall St Screener to uncover fresh opportunities before they are crowded, and avoid feeling like you only spot them after the big moves.
- Target potential value opportunities by scanning companies highlighted in the 44 high quality undervalued stocks that combine compressed prices with stronger underlying fundamentals.
- Prioritise resilience by checking out companies in the 68 resilient stocks with low risk scores that score well on balance sheet strength and business stability.
- Get ahead of the crowd by reviewing the screener containing 19 high quality undiscovered gems and finding quality stocks that are not yet widely on investors’ radars.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
